参考文献:1.Roubelakis A, Moorjani N, Gallagher P, Ohri SK. Aortic root and hemiarch replacement in osteogenesis imperfecta. Asian Cardiovasc Thorac Ann. 2012;20:68–70.CrossRef PubMed 2.Stein D, Kloster FE. Valvular heart disease in osteogenesis imperfecta. Am Heart J. 1977;94(5):637–41.CrossRef PubMed 3.Byers PH, Steiner RD. Osteogenesis Imperfecta. Annu Rev Med. 1992;43:269–82.CrossRef PubMed 4.Radunovic Z, Wekre LL, Diep LM, Steine K. Cardiovascular abnormalities in adults with osteogenesis imperfecta. Am Heart J. 2011;161(3):523–9.CrossRef PubMed 5.Bonita RE, Cohen IS, Berko BA. Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography. 2010;27(1):69–73.CrossRef PubMed 6.Wong RS, Follis FM, Shively BK, Wernly JA. Osteogenesis imperfecta and cardiovascular diseases. Ann Thorac Surg. 1995;60(5):1439–43.CrossRef PubMed 7.McKay R, Yacoub MH. Clinical and pathological findings in patients with “floppy” valves treated surgically. Circulation. 1973;48(1 Suppl III):63–73. 8.Azuma T, Yamazaki K, Saito S, Kurosawa H. Aortic valve replacement in Behcet’s disease: surgical modification to prevent valve detachment. Eur J Cardio Thorac Surg. 2009;36:771–2.CrossRef 9.Dellgren G, Feindel CM, Bos J, Ivanov J, David TE. Aortic valve replacement with the Toronto SPV: long-term clinical and hemodynamic results. Eur J Cardiothorac Surg. 2002;21(4):698–702.CrossRef PubMed 10.Jamieson WR, Riess FC, Raudkivi PJ, Metras J, Busse EF, Goldstein J, et al. Medtronic mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg. 2011;142(2):302–7.CrossRef PubMed 11.McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg. 2010;89(5):1410–6.CrossRef PubMed 12.Lamanna A, Fayers T, Clarke S, Parsonage W. Valvular and aortic disease in osteogenesis imperfecta. Heart Lung Circ. 2013;20(10):801–10.CrossRef 13.Koentges D, van de Werf F, Stalpaert J, Goddeeris P, de Geest H. Aortic and mitral valve replacement in osteogenesis imperfect. Report of a case. Acta Cardiol. 1986;41(2):147–53.PubMed 14.Aoki T, Kuraoka S, Ohtani S, Kuroda Y. Aortic valve replacement in a woman with osteogenesis imperfecta. Ann Thorac Cardiovasc Surg. 2002;8(1):51–3.PubMed 15.Bennett JM, Gourassas J, Stevens S. Double valve replacement in a patient with osteogenesis imperfecta. Eur J Cardiothorac Surg. 1987;1:46–8.CrossRef PubMed
1. Department of Cardiovascular Surgery, Graduate School of Medicine, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan 2. Department of Pathology, Graduate School of Medicine, Nagasaki University, Nagasaki, Japan
Osteogenesis imperfecta (OI) is an inherited connective tissue disorder. Left ventricle dilation and valve insufficiency are complications in patients with OI and such patients are at high risk of mortality and complications related to bleeding and tissue friability during cardiac surgery. Valve dehiscence due to extreme friability of the annulus is a major complication of cardiac valve replacement with OI. We describe OI in a male patient who underwent double valve replacement with mechanical valves using a tissue protective method to prevent valve dehiscence.